IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $20,378,000 | +44.0% | 575,000 | -45.2% | 5.38% | +43.2% |
| Q1 2020 | $14,154,000 | +33.8% | 1,050,000 | +110.0% | 3.75% | +86.3% |
| Q4 2019 | $10,580,000 | -58.6% | 500,000 | -74.0% | 2.02% | -69.0% |
| Q3 2019 | $25,539,000 | +31.5% | 1,926,000 | +37.6% | 6.51% | +61.6% |
| Q2 2019 | $19,418,000 | +26.4% | 1,400,000 | +75.0% | 4.03% | +0.3% |
| Q1 2019 | $15,368,000 | -32.7% | 800,000 | -50.0% | 4.02% | -51.5% |
| Q4 2018 | $22,832,000 | +24.0% | 1,600,000 | +81.0% | 8.29% | +111.8% |
| Q3 2018 | $18,410,000 | -37.8% | 883,823 | -29.3% | 3.91% | -55.1% |
| Q2 2018 | $29,588,000 | +9.5% | 1,250,000 | -32.4% | 8.71% | +59.3% |
| Q1 2018 | $27,029,000 | -41.1% | 1,850,000 | -34.8% | 5.47% | -49.2% |
| Q4 2017 | $45,862,000 | +68.5% | 2,838,000 | +45.8% | 10.75% | +86.1% |
| Q3 2017 | $27,218,000 | +156.9% | 1,946,946 | +62.2% | 5.78% | +162.5% |
| Q2 2017 | $10,596,000 | +9.2% | 1,200,000 | -20.0% | 2.20% | +21.7% |
| Q1 2017 | $9,705,000 | +55.6% | 1,500,000 | -11.8% | 1.81% | +20.4% |
| Q4 2016 | $6,239,000 | -4.0% | 1,700,000 | -15.0% | 1.50% | +42.5% |
| Q3 2016 | $6,500,000 | +133.5% | 2,000,000 | +66.7% | 1.05% | +31.1% |
| Q2 2016 | $2,784,000 | – | 1,200,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|